1. The analysis of the cost and amputation rates of hospitalized diabetic foot infection patients
- Author
-
Gül Karagöz, Ayten Kadanalı, Sinan Öztürk, Şule Eren Çakar, Şenol Çomoğlu, and Fidan Doğan
- Subjects
medicine.medical_specialty ,business.industry ,Hospitalized patients ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,030209 endocrinology & metabolism ,medicine.disease ,Diabetic foot ,Surgery ,03 medical and health sciences ,Indirect costs ,0302 clinical medicine ,Amputation ,Diabetes mellitus ,Health care ,Emergency medicine ,Internal Medicine ,medicine ,030212 general & internal medicine ,Foot ulcers ,business ,Major amputation - Abstract
Direct and indirect costs of diabetes and its complications figure prominently in health care expenditure globally. The diabetic foot is one of the most common complications of diabetes and is usually associated with neurological and peripheral vascular problems, yielding foot ulcers and infection. The aim of this study was to analyze hospitalized diabetic foot patient costs and amputation rate changes over time. Hospitalized patients with infected diabetic foot ulcerations within a 4-year span, starting in January 2012, were retrospectively evaluated to analyze cost and amputation rate changes over time. One hundred thirty-eight diabetic patients were hospitalized and treated. Major amputation rates tended to increase; however, minor amputation rates tended to decrease over time. Mean cost per patient was $2880. The distribution of the costs according to the years was not significant. Treatment of infected diabetic foot ulceration is challenging and incurs high healthcare costs. Through intensive foot care and multidisciplinary team approaches, major amputation rates have gradually increased in recent years.
- Published
- 2016
- Full Text
- View/download PDF